Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells

Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease

(2011) S. D'Souza et al.   BLOOD

Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma

(2011) Noopur Raje et al.   CLINICAL CANCER RESEARCH

Update on Wnt signaling in bone cell biology and bone disease

(2011) David G. Monroe et al.   GENE

WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production

(2011) Martina Rauner et al.   JOURNAL OF BONE AND MINERAL RESEARCH

WNT5A induces osteogenic differentiation of human adipose stem cells via rho-associated kinase Rock

(2010) Ana Santos et al.   CYTOTHERAPY

Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium Ranelate

(2010) Olivia Fromigué et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Wnt signal transduction pathways

(2010) Yuko Komiya et al.   Organogenesis

Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma

(2009) M. Fulciniti et al.   BLOOD

Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth

(2008) Y.-W. Qiang et al.   BLOOD

The role of Dickkopf-1 in bone development, homeostasis, and disease

(2008) J. J. Pinzone et al.   BLOOD

Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase

(2008) Yan Liu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Wnt signaling and skeletal development

(2007) Fei Liu et al.   CELLULAR SIGNALLING